Valuation: OraSure Technologies, Inc.

Market Cap 258M 230M 213M 193M 363M 24.47B 369M 2.56B 1B 12.8B 969M 949M 40.85B P/E 2026 *
-5.67x
P/E 2027 * -4.62x
Enterprise Value 258M 230M 213M 193M 363M 24.47B 369M 2.56B 1B 12.8B 969M 949M 40.85B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.94x
Free-Float
93.51%
Yield 2026 *
-
Yield 2027 * -
1 day+1.77%
1 week-1.71%
Current month-4.46%
1 month+5.20%
3 months-2.73%
6 months+17.40%
Current year+54.75%
1 week 3.59
Extreme 3.59
3.83
1 month 3.59
Extreme 3.59
4.13
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
11.45
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 2022-06-03
Director of Finance/CFO 54 2022-08-07
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 2020-05-31
Director/Board Member 66 2021-11-07
Director/Board Member 52 2022-06-03
Date Insider Type Main position Quantity % Market Cap. Importance
9/29/26 Free

Director

4,797 0.0070%
9/6/26 Tax

Chairman

-5,116 0.0074%
6/3/26 Free

Director

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
+1.77%-1.71%+23.19%-30.00% 258M
-1.55%-0.16%-20.89%+5.86% 177B
+2.17%+7.73%-20.15%+14.57% 117B
+2.00%+1.74%-1.34%+30.17% 116B
-1.02%+2.87%-52.05%-7.70% 77.71B
+0.96%+3.99%+4.85%+81.86% 65.51B
+1.98%+4.35%+15.64%+82.79% 54.97B
+1.60%+3.43%+1.47%-25.07% 52.79B
+0.38%+7.23%-13.29%+30.66% 43.95B
-0.28%+0.80%+25.30%-0.27% 32.35B
Average +0.80%+2.42%-3.73%+18.29% 73.74B
Weighted average by Cap. +0.54%+3.04%-11.88%+21.10%

Financials

2026 *2027 *
Net sales 122M 109M 101M 91.28M 172M 11.57B 174M 1.21B 475M 6.05B 458M 449M 19.31B 133M 119M 110M 99.57M 187M 12.62B 190M 1.32B 518M 6.6B 500M 489M 21.07B
Net income -46.2M -41.12M -38.11M -34.53M -64.9M -4.38B -65.99M -457M -180M -2.29B -173M -170M -7.31B -57.65M -51.32M -47.56M -43.1M -81M -5.46B -82.35M -571M -224M -2.86B -216M -212M -9.12B
Net Debt - -
Projected Income Statement - Annual - OraSure Technologies, Inc.
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
26-10-20 $3.745 +1.77% 406,439
26-10-19 $3.680 +1.94% 659,171
26-10-16 $3.610 -5.25% 317,870
26-10-15 $3.810 +2.70% 590,893
26-10-14 $3.710 -2.62% 355,981
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - OraSure Technologies, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.745USD
Average target price
4.000USD
Spread / Average Target
+6.81%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OraSure Technologies, Inc.
  1. Stock Market
  2. Stocks
  3. OSUR Stock